Key result
Transcutaneous pacing successfully interrupts tachyarrhythmias in ~52% of patients with VT or SVT.
Why the study?
The effectiveness and safety of transcutaneous cardiac pacing for interruption of ventricular and supraventricular tachyarrhythmias needed evaluation.
Does transcutaneous cardiac pacing effectively terminate tachyarrhythmias in patients with VT, AVRT, or AVNT?
Comparison
Overdrive pacing vs underdrive pacing using transcutaneous cardiac pacing
Design
Case series
Authors
Loading...
May support noninvasive termination of select reentrant tachycardias; hypothesis-generating case data leave efficacy and safety open for prospective trials.
Does transcutaneous cardiac pacing effectively terminate tachyarrhythmias in patients with VT, AVRT, or AVNT?
Transcutaneous cardiac pacing is an effective method for terminating ventricular and supraventricular reentrant tachycardias, though it carries a risk of arrhythmia worsening.
Altamura et al. (1990) studied Tachyarrhythmias (n=31). Transcutaneous cardiac pacing was evaluated on Interruption of tachyarrhythmias. Transcutaneous cardiac pacing successfully interrupted tachyarrhythmias in 8 of 20 patients with ventricular tachycardia and 8 of 11 patients with supraventricular tachycardia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: